期刊文献+

EPDR1对肝细胞脂质沉积的影响

Effect of EPDR1 on hepatocyte lipid deposition
下载PDF
导出
摘要 目的:检测室管膜素相关蛋白1(EPDR1)在野生型C57BL/6小鼠各组织中的表达情况;观察2型糖尿病状态下,小鼠各组织中EPDR1的表达;探讨EPDR1对AML12肝细胞脂质沉积的影响。方法:采用Western blot检测C57BL/6小鼠心、肝、脾、肺、肾、腓肠肌、棕色脂肪以及脑组织中EPDR1蛋白的表达;Western blot和免疫组织化学(IHC)染色比较db/db小鼠与C57BL/6小鼠肝、腓肠肌、心和肾组织中EPDR1蛋白表达情况。采用油酸和棕榈酸联合诱导AML12细胞建立脂质沉积模型,且经腺病毒过表达EPDR1和给予外源重组蛋白EPDR1(rEPDR1)干预,ELISA测定胞内甘油三酯(TG)含量,油红O染色评估EPDR1对AML12细胞脂质沉积的影响。结果:Western blot和IHC均显示EPDR1广泛表达于野生型小鼠心、肝、脾、肺、肾、腓肠肌、棕色脂肪和脑组织中,且在肝脏中蛋白表达最高;而在糖尿病db/db小鼠肝、腓肠肌、心和肾组织中较野生型小鼠表达下调;油红O染色结果显示,过表达EPDR1或给予rEPDR1均可减少AML12肝细胞中脂质沉积,且TG含量较模型组下降(P<0.05)。结论:EPDR1广泛表达在野生型小鼠各个组织,且在糖尿病小鼠肝脏组织中表达下调,而上调EPDR1可以缓解肝细胞中的脂质沉积。本研究为进一步揭示EPDR1在糖尿病肝组织脂肪变中的作用奠定实验基础。 AIM:This study aims to examine the ependymin-related protein 1(EPDR1)expression in various tissues from wild-type C57BL/6 mice and type 2 diabetes(db/db)mice.The impact of EPDR1 on lipid accumulation in alpha mouse liver 12(AML12)hepatocytes was also investigated.METHODS:Western blot was used to detect EPDR1 protein expression in the heart,liver,spleen,lung,kidney,gastrocnemius,brown adipose and brain tissues of C57BL/6 mice.Western blot and immunohistochemical(IHC)staining were also used to compare EPDR1 protein expression in the liver,gastrocnemius muscle,heart and kidney tissues of db/db and C57BL/6 mice.To develop an AML12 cell lipid deposition model,palmitic acid(PA)+oleic acid(OA)was used,and the cells were transfected with adenovirus overexpressing EPDR1 or treated with exogenous recombinant EPDR1 protein(rEPDR1).ELISA was conducted to determine intracellular triglyceride(TG)content,and oil red O staining was employed to assess the effect of EPDR1 on lipid accumulation in AML12 cells.RESULTS:Western blot and IHC staining results revealed that EPDR1 was widely expressed in various tissues of wild-type mice,with the liver exhibiting the highest protein expression level.However,EPDR1 expression was down-regulated in the liver,gastrocnemius muscle,heart and kidney tissues in diabetic db/db mice compared with wild�type mice.Oil red O staining revealed that overexpression of EPDR1 in AML12 liver cells or rEPDR1 treatment led to reduced lipid accumulation.Furthermore,the TG content significantly decreased compared with the model group(P<0.05).CONCLUSION:EPDR1 is expressed in various tissues of wild-type mice,but showed diminished expression in the liver tissues of diabetic mice.Nevertheless,enhancing the expression of EPDR1 can aid in reducing lipid accumulation in hepatocytes.These findings provide an experimental foundation for further exploration of the role of EPDR1 in the development of fatty liver in diabetic liver tissue.
作者 王贵芳 常雪冰 扈腊英 刘露 黄亚莉 宋铃榆 周宇霞 郭兵 WANG Guifang;CHANG Xuebing;HU Laying;LIU Lu;HUANG Yali;SONG Lingyu;ZHOU Yuxia;GUO Bing(Department of pathophysiology,Guizhou Medical University/Guizhou Key Laboratory of Pathogenesis and Drug Research ofCommon Chronic Diseases,Anshun 561113,China)
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2024年第7期1205-1212,共8页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.32160207) 贵州省科技厅计划项目(黔科合基础-ZK[2021]一般402号) 贵州医科大学国家自然科学基金培育项目(No.19NSP040) 贵州医科大学优秀青年人才计划(No.2021105)。
关键词 室管膜素相关蛋白1 2型糖尿病 肝细胞 脂质沉积 ependymin-related protein 1 type 2 diabetes mellitus hepatocytes lipid deposition
  • 相关文献

参考文献5

二级参考文献89

  • 1[1]Clark JM,Brancati FL,Diehl AM.Nonalcoholic fatty liver disease.Gastroenterology 2002; 122:1649-1657
  • 2[2]Franzese A,Vajro P,Argenziano A,Puzziello A,Iannucci MP,Saviano MC,Brunetti F,Rubino A.Liver involvement in obese children.Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population.Dig Dis Sci 1997; 42:1428-1432
  • 3[3]Tominaga K,Kurata JH,Chen YK,Fujimoto E,Miyagawa S,Abe 1,Kusano Y.Prevalence of fatty liver in Japanese children and relationship to obesity.An epidemiological ultrasonographic survey.Dig Dis Sci 1995; 40:2002-2009
  • 4[4]Browning JD,Szczepaniak LS,Dobbins R,Nuremberg P,Horton JD,Cohen JC,Grundy SM,Hobbs HH.Prevalence of hepatic steatosis in an urban population in the United States:impact of ethnicity.Hepatology 2004; 40:1387-1395
  • 5[5]Neuschwander-Tetri BA.Nonalcoholic steatohepatitis and the metabolic syndrome.Am J Med Sci 2005; 330:326-335
  • 6[6]Adams LA,Lymp JF,St Sauver J,Sanderson SO,Lindor KD,Feldstein A,Angulo P.The natural history of nonalcoholic fatty liver disease:a population-based cohort study.Gastroenterology 2005; 129:113-121
  • 7[7]Browning JD,Horton JD.Molecular mediators of hepatic steatosis and liver injury.J Clin Invest 2004; 114:147-152
  • 8[8]Machado M,Cortez-Pinto H.Non-alcoholic steatohepatitis and metabolic syndrome.Curr Opin Clin Nutr Metab Care 2006; 9:637-642
  • 9[9]Seppala-Lindroos A,Vehkavaara S,Hakkinen AM,Goto T,Westerbacka J,Sovijarvi A,Halavaara J,Yki-Jarvinen H.Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.J Clin Endocrinol Metab 2002; 87:3023-3028
  • 10[10]Loria P,Lonardo A,Carulli N.Should nonalcoholic fatty liver disease be renamed? Dig Dis 2005; 23:72-82

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部